CClinicalTrials.gg
CompletedNCT07596836SITUpdated May 22, 2026

Sprint Interval Training in Young Sedentary Adults

An interventional study of Sprint Interval Training in Sedentary Lifestyle and Cardiorespiratory Fitness, sponsored by Sezer Taştan. Completed at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Sezer Taştan · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 25 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated the effects of a 6-week supervised sprint interval training program on cardiorespiratory fitness in healthy sedentary young adults. Forty participants aged 20 to 25 years were randomly assigned to either a sprint interval training group or a control group. The sprint interval training group completed supervised cycle-ergometer sessions three times per week for 6 weeks, while the control group maintained their usual sedentary routine. The primary outcome was maximal oxygen uptake (VO2max). Secondary outcomes included resting heart rate and 6-minute walk test distance. The study aimed to determine whether a short-term, time-efficient sprint interval training program could improve cardiovascular capacity and functional exercise performance in sedentary young adults.

Read the detailed description

This study was designed as a randomized controlled pre-test and post-test intervention study. Healthy sedentary adults aged 20 to 25 years were enrolled after ethics approval and written informed consent. Participants were randomly allocated in a 1:1 ratio to either a supervised sprint interval training group or a control group.

The sprint interval training group performed supervised exercise sessions on a cycle ergometer three times per week for 6 weeks. Each session included a 5-minute warm-up, followed by repeated 30-second all-out sprint bouts with active recovery periods. The number of sprint repetitions was progressively increased during the intervention period. The control group maintained their usual sedentary lifestyle and did not receive an additional exercise program.

Outcome measurements were performed before and after the intervention. The primary outcome was VO2max, assessed using a maximal exercise test on a cycle ergometer with respiratory gas analysis. Secondary outcomes were resting heart rate and 6-minute walk test distance. Adherence and adverse events were monitored throughout the study period.

02

Conditions studied

  • Sedentary Lifestyle
  • Cardiorespiratory Fitness

Browse trials for

Keywords

  • Sprint interval training
  • VO2max
  • Cardiorespiratory fitness
  • Resting heart ratev
  • 6-minute walk test
  • Sedentary adults
  • Young adults
  • Randomized controlled trial
03

In context

Sedentary Behavior

332 studies on the registry are indexed under Sedentary Behavior; 155 are open to participants now.

This study's enrollment of 40 is below the median of 70 across 287 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

This is the only study on the registry with Sezer Taştan as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 20-25 years
  • Healthy sedentary adult
  • Engaging in less than 150 minutes/week of moderate-to-vigorous physical activity
  • IPAQ score below 600 MET-min/week or not participating in a regular exercise program
  • Willing to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • History of cardiovascular, pulmonary, or metabolic disease, such as hypertension or diabetes
  • Musculoskeletal injury or orthopedic condition preventing exercise participation
  • Pregnancy or breastfeeding
  • Smoking
  • Regular medication use
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Sprint Interval Training Group

    Participants in this group completed supervised sprint interval training sessions on a cycle ergometer three times per week for 6 weeks.

    Behavioral: Sprint Interval Training

  • No intervention
    Control Group

    Participants in this group maintained their usual sedentary routine and did not receive an additional exercise program during the study period.

Interventions

  • BehavioralSprint Interval Training

    The sprint interval training intervention consisted of supervised cycle-ergometer sessions performed three times per week for 6 weeks. Each session included a 5-minute warm-up at 50% VO2max, followed by 4 to 6 repetitions of 30-second all-out sprint bouts on a Monark 894E cycle ergometer, with 4-minute active recovery periods between sprints. The number of sprint repetitions was progressively increased from 4 repetitions in the first two weeks to 6 repetitions in the following four weeks.

    Also known as: SIT

06

What researchers measure

Primary outcomes

  1. Change in Maximal Oxygen Uptake (VO2max)

    VO2max was assessed using a maximal exercise test on a cycle ergometer with breath-by-breath respiratory gas analysis. VO2max values were recorded in ml/kg/min before and after the 6-week intervention.

    Time frame: Baseline and 6 weeks

Secondary outcomes

  1. Change in Resting Heart Rate

    Resting heart rate was measured in the morning after 10 minutes of seated rest using a heart rate monitor. Values were recorded in beats per minute before and after the 6-week intervention.

    Time frame: Baseline and 6 weeks

  2. Change in 6-Minute Walk Test Distance

    Functional exercise capacity was assessed using the 6-minute walk test. The total distance covered in 6 minutes was recorded in meters before and after the 6-week intervention.

    Time frame: Baseline and 6 weeks

07

Study locations

1 site
  • Ankara Demirspor
    Ankara, Ankara 06000, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07596836
Lead sponsor
Sezer Taştan
Responsible party
Sezer Taştan (Principal Investigator, Ankara Demirspor Kulubu) — Sponsor-investigator
First posted
May 19, 2026
Start date
Mar 11, 2026
Primary completion
Apr 22, 2026
Completion
Apr 22, 2026
Last update
May 22, 2026

Study contacts

Sezer Taştan, phD
principal investigator · Ankara Demirspor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion